ArticleFrontiers in oncology2024

Efficacy and safety of anlotinib combined with immune checkpoint inhibitors and platinum-containing chemotherapy for later-line advanced non-small cell lung cancer: a retrospective three-arm real-world study using propensity-score matching.

Zeyang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.